Summary
Former President Donald Trump announced an upcoming significant autism-related revelation from his administration at a memorial service. The announcement is set to address potential links between autism and acetaminophen use during pregnancy, with an emphasis on leucovorin as a treatment. Key health officials are involved in shaping this initiative.
Key Facts
- Trump announced a major autism-related announcement will occur on September 22.
- Officials are exploring links between acetaminophen use in pregnancy and autism.
- Leucovorin, a treatment for vitamin B9 deficiency, is being considered for autism treatment.
- FDA Commissioner Marty Makary and NIH Director Jay Bhattacharya are involved.
- Trump made the announcement during a memorial for Charlie Kirk in Arizona.
- Health Secretary Robert F. Kennedy Jr. and Dr. Mehmet Oz will join Trump for the announcement.
- The plan includes reviewing research from Mount Sinai and Harvard on autism.
- The White House describes the upcoming announcement as a significant medical event.
